These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficacy of rivastigmine in comparison to ginkgo for treating Alzheimer's dementia. Nasab NM; Bahrammi MA; Nikpour MR; Rahim F; Naghibis SN J Pak Med Assoc; 2012 Jul; 62(7):677-80. PubMed ID: 23866514 [TBL] [Abstract][Full Text] [Related]
6. A novel treatment for patients with Alzheimer's disease and with vascular dementia. Kurz A Ann N Y Acad Sci; 2002 Nov; 977():476-81. PubMed ID: 12480788 [No Abstract] [Full Text] [Related]
7. Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease treated with galantamine. Lilienfeld S; Kurz A Ann N Y Acad Sci; 2002 Nov; 977():487-92. PubMed ID: 12480790 [No Abstract] [Full Text] [Related]
8. [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)]. Damulin IV Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):65-7. PubMed ID: 19938276 [No Abstract] [Full Text] [Related]
9. Conflicting results on ginkgo research. Le Bars P Forsch Komplementarmed Klass Naturheilkd; 2002 Feb; 9(1):19-20. PubMed ID: 11968151 [No Abstract] [Full Text] [Related]
10. Placebos in clinical trials in Alzheimer disease: an international discussion. Whitehouse PJ; Arizaga R; Brodaty H; Gauthier S; Graham N; Green RC; Homma A; Mangone C; Senanarong V; Xu XH Alzheimer Dis Assoc Disord; 1999; 13(3):121-3. PubMed ID: 10485568 [No Abstract] [Full Text] [Related]
11. [Preliminary assessment of ginkgo biloba (Ginkofar) in patients with dementia]. Bidzan L; Biliekiewicz A; Turczyński J Psychiatr Pol; 2005; 39(3):559-66. PubMed ID: 16149765 [TBL] [Abstract][Full Text] [Related]
12. [External validity of clinical trials for treatment of dementia with ginkgo biloba extracts]. Bornhöft G; Maxion-Bergemann S; Matthiessen PF Z Gerontol Geriatr; 2008 Aug; 41(4):298-312. PubMed ID: 18327688 [TBL] [Abstract][Full Text] [Related]
13. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council. Fillit H; Cummings J Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691 [TBL] [Abstract][Full Text] [Related]
14. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. Mazza M; Capuano A; Bria P; Mazza S Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364 [TBL] [Abstract][Full Text] [Related]
15. [Guidelines for the treatment of dementias]. Trabucchi M; Bianchetti A Recenti Prog Med; 2000 Sep; 91(9):444-9. PubMed ID: 11021167 [No Abstract] [Full Text] [Related]
16. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Expert Consensus Panel for Dementia Postgrad Med; 2005 Jan; Spec No():1-111. PubMed ID: 17203560 [No Abstract] [Full Text] [Related]
17. [Galantamine (reminyl) in the treatment of Alzheimer's disease and vascular dementia]. Gavrilova SI; Zharikov GA Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(12):59-65. PubMed ID: 14763262 [No Abstract] [Full Text] [Related]
18. Pharmacologic treatment of Alzheimer's disease: an update. DeLaGarza VW Am Fam Physician; 2003 Oct; 68(7):1365-72. PubMed ID: 14567491 [TBL] [Abstract][Full Text] [Related]